RE: SKIN will move towards 30m to 50m within a year.12 Sep 2019 13:31
Please spend a bit of time looking at the company it is not a rainbow chasing share, it is a solid business model which is being noticed and respected by huge companies. But most importantly....
This is a revenue-making business already, people seem to have missed this. It has a large pipeline of orders and is growing to meet demand from top ten companies. They are effectively cherry-picking the big players rather than just taking anyone who comes along but don't for a second think the demand from both big and small organizations is not there. It is and will only continue to grow exponentially.
SKIN will move towards 30m to 50m within a year as those bigger contracts start rolling in.
RE: I didn’t get the chance to add12 Sep 2019 09:25
Looks fairly valued to me price floats around. Some have sold and moved on just as the story start d to get exciting. Lot of one off costs, debt paid down, legacy tax and fees cleared up. As well as equipment and lab expansion costs. These will not be on going.
So will be easier to grow from here. Especially as the parts of the business that were not performing have been disposed of. Leaving the team to improve and develop the cream of the crop.
The company is progressing steady and looks very promising to me. Sure I want the price higher but it will get back up this much I am certain of. So as the deals are done and relationships made we are fortunate enough to be getting shares down here.
One or two big contracts, partnerships or agreements and this price is gone. I also believe that the company is well positioned and able to win these bigger contracts. It is management I am comfortable leaving to my money with.
Lots of points I loved, *more than enough cash, *large pipe, companies signed that we can’t mention due to ndas but you have them in your home. * in talks for future deals that run to 7 figures * biggest problem is too much demand
I also liked the once in you are in comment, I used to work in law and intellectual property and the same applies. Once that foot is in the door you are golden for long term future recurring revenue.
All in all I thought it was a cracking interview and a good set of interims. Market will catch up when big contracts start flooding in.
Until then I am happy to continue holding and buying weakness.
The sun is so bright I only managed the first seven mins of interview but will play the rest later.
They are presenting on Sunday so you need to click the link for Sunday and then click business pro and there they are! Paul Ryan & David Caballero-Lima – (Labskin) How to anticipate regulation and get ahead of the industry